Connect with us

Share Market

$MARK DD – There Is Potential

Published

on



MARK was the most chosen stock so here is the DD for it.

Bagholders will like this.

TL;DR at the end.

Catalysts:

https://finance.yahoo.com/news/remark-holdings-sets-first-quarter-203000891.html

During the conference call, their management will be discussing other topics apart from financial results.

They will be providing updates on their AI businesses in Asia and the U.S.

Thermal and security screening will also be discussed.

Since there corona cases are spiking, there is potential for them to announce a partnership with other companies.

Some rumors have been going around about a possible partnership with an airport but those are all rumors.

Their thermal cameras will be of great help to any business that has a constant flow of people so the possible partnerships are limitless.

The AI news could be huge. MARKs AI Thermal cameras are amazing for the Asia Market especially since China has recently reported a lot of corona cases.

Their thermal cameras are perfect for dense countries so China could be a big client for MARK.

https://finance.yahoo.com/news/remark-tech-combat-covid-19-100245088.html

Their thermal cameras are in very high demand right now and they are closing deals with business left and right.

MARK has made a deal with China Mobile to provide all of its 17,800 stores with AI technology enabling “facial-ID, traffic counting, and smart queue management.”

This data will allow the company to streamline and optimize traffic flow in its stores by giving customers information about the nearest stores and number of customers in each one, and it allows them to get in line for a customer service agent before they arrive, via an online ticketing system.

Such technology can significantly improve customer service, making for happier customers and a more successful brand. Additionally, by reducing foot traffic, these solutions can slow the spread of coronavirus and help companies operate smoothly with reduced physical capacity in stores.

The potential revenue on this deal would be massive.

Considering that the thermal cameras aren't the cheapest, it would cost China Mobile millions of dollars to equip all their 17,800 stores.

MARK is going to have their wallers filled with straight-up cash which they will be using to further expand their business and technology.

https://finance.yahoo.com/news/remark-stock-pandemic-proof-bet-145421478.html

Their app Sharecare has already been launched and will be providing users with virtual healthcare.

Sharecare offers AI-enhanced healthcare and it’s had a lot of attention from celebrities like Oprah Winfrey and Dr. Oz. Celebrity.

Virtual healthcare offers a cheaper alternative to visiting healthcare professionals, which is an important factor in the Presidential campaign in which healthcare costs will once again be a big thing. Plus, the pandemic forced people to use remote healthcare services.

As there are more cases, more people will be using Sharecare which will further improve revenues and publicity for MARK.

TDOC is a powerful example of how growing interest in virtual healthcare was accelerated by the pandemic.

The company said that the number of virtual visits it facilitated at the start of April was more than 100% higher than in March. Demand for virtual healthcare will likely continue to be strong going forward.

If MARK can successfully pull off what TDOC is doing, the stock will skyrocket with their revenues.

Financials:

https://www.sec.gov/Archives/edgar/data/1368365/000136836520000038/a12b-25forform10xq2020q1.htm

I'm very surprised to say this but MARK has not reported any financials at all for this year.

I will not be basing any financials on their last year's financials form since it does not accurately represent the financials that the company has today.

There could be multiple reasons for not reporting any financials, I do not know which one it is but I do know that not reporting financials negatively affects the company and reduced the number of people willing to invest.

https://finance.yahoo.com/news/remark-holdings-sets-first-quarter-203000891.html

They are currently planning on releasing some financials very soon but still, not reporting financials at the right time is never good.

Date: Monday, July 6, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-Free Number: 866.548.4713International Number: 323.794.2093Conference ID: 1160760

This doesn't necessarily mean the financials will be bad especially with all the catalysts. I actually expect their financials to be somewhat good.

Fundamentals:

https://finance.yahoo.com/quote/MARK/profile?p=MARK

Here's a description of the company:

Remark Holdings, Inc., technology-focused company, develops and deploys artificial intelligence (AI) products and AI-based solutions for businesses in various industries worldwide.

It operates through two segments, Travel & Entertainment, and Technology & Data Intelligence. The company operates KanKan, a data intelligence platform that offers AI-based vision products, computing devices, and software-as-a-service products for the financial, retail, entertainment, education, and workplace and public safety industries.

It also owns and operates various digital media properties that deliver content in various verticals, including travel and entertainment, such as lodging, air travel, show tickets, and tours through Vegas.com and its related Websites comprising LasVegas.com, as well as mobile applications and retail locations; and young adult lifestyle that includes Bikini.com, an e-commerce Website, which sells swimwear and accessories.

In addition, the company sells financial-technology products and services, as well as advertising services through its Websites.

The company was formerly known as Remark Media, Inc. and changed its name to Remark Holdings, Inc. in April 2017. Remark Holdings, Inc. was founded in 2006 and is headquartered in Las Vegas, Nevada.

Their Address:

3960 Howard Hughes ParkwaySuite 900Las Vegas, NV 89169United States702-701-9514http://www.remarkholdings.com

They have no full-time employees.

It's good that they are located in the U.S. this opens up a lot of potential clients.

Technicals:

Stock Info:

Usual 10-day volume of 8.23M.

– Usual 3-month volume of 34.32M.

This is a very good volume for a penny stock, it provides easy buying and selling of the stock and it ensures that there will be movement in the stock price.

– Shares outstanding are 99.38M.

– Float is 85.71M.

It would be better to see a lower float since the lower the float the easier it is to move up the stock price, but this isn't a bad float.

Not that many benefits from a float like this other than it's harder to push down the price but the same goes for trying to push up the price.

– 26.23% of shares are being held by insiders.

– 14.19% of shares are being held by institutions.

So many insiders holding the stock could cause a massive dump in the stock price if they decided to sell-off.

It isn't all bad though, this also shows that the insiders are confident that the stock price will go up since it is part of their paycheck.

A good number of institutions hold the stock, institutions usually invest in stocks that will increase in price.

– Short % of float is 15.43%

– Short % of shares outstanding is 14.52%.

This is both good and bad. The good is that there is potential for a big short squeeze which will force many people to start mass buying the stock, this will of course boost the stock price by quite a bit.

The bad part is that this shows that a good part of investors aren't confident that the stock price will go up. The lower the confidence the more paper hands traders there will be which will make the price fall.

Indicators:

These are based on the 1-day indicators.

Moving Averages:

– Candles above 5 SMA, buy rating.

– Candles below 10 SMA, sell rating.

– Candles below 20 SMA, sell rating.

– Candles below 30 SMA, sell rating.

– Candles above 50 SMA, buy rating.

– Candles above 100 SMA, buy rating.

– Candles above 200 SMA, buy rating.

– Candles are neutral on IC, hold rating.

– Candles are below VWAP, sell rating.

– Candles are above HMA, buy rating.

Moving Averages give MARK a buy rating. MARK is in a short term downtrend but an overall uptrend.

Oscillators:

– Stock is neutral on RSI, hold rating.

– Stock is positive on R%S, buy rating.

– Stock is neutral on CCI, hold rating.

– Stock is neutral on ADI, hold rating.

– Stock is negative on AO, sell rating.

– Stock is negative on Momentum, sell rating.

– Stock is negative on MACD, sell rating.

– Stock is neutral on SRF, hold rating.

– Stock is neutral on WPR, hold rating.

– Stock is neutral on BPP, hold rating.

– Stock is neutral on UO, hold rating.

Oscillators give MARk a sell rating

Overall, indicators give MARK a sell rating.

Support And Resistances:

– Hourly support of $2.31.

– Hourly resistance of $2.44.

– Daily support of $1.08.

– Daily resistance of $3.56.

TL;DR: MARK is a sort of short term play, I recommend selling it off when they announce their financials and other plans on July 6.

With cases rising, MARK will be a hot stock, their thermal cameras are in very high demand all across the world and potential partnerships and deals are limitless.

China Mobile has made a deal with MARK to equip their 17,800 stores with thermal cameras. MARK will be making bank on this deal and will use the money to improve its technology which will further potential revenue.

MARKs app Sharecare could become a big success. Most people will not be leaving their houses and Sharecare will take advantage of that by bringing virtual healthcare to people. The potential revenue on this one is massive.

The conference will hopefully boost the stock price by quite a bit considering that they will be discussing so many things.

TL;DR;DR: These are some quick buy and sell points.

– Buy point is if MARK rebounds to around $2.33-$2.29.

– Instant buy point is if MARK breaks the $2.61 hourly resistance with some buffer.

– Sell point is if MARK falls below the hourly 50 SMA.

– Instant sell point is if MARK falls below the hourly $2.13 support.

Remember, this is not a very short term play, July 6 will be a big day for the stock.

Please take everything with a grain of salt, markets are being volatile.

These points are more suited for the volatility of the market and should work better than before.

This is not financial advice, I'm not a financial professional.

Do not buy this stock just because of this DD.

I'm not to be held liable for any losses or missed out gains due to this DD.

I do not currently hold any shares of this stock.

Please trade responsibly and take days off when your account is falling.

submitted by /u/Bogashi
[comments]



Source link

قالب وردپرس

Share Market

WARNING: 3 Ways the CRA Can Take Back Your $2,000 CERB!

Published

on


If you are a Canadian citizen who has been out of work due to the ongoing health crisis, you might already be receiving the Canada Emergency Response Benefit (CERB) payments from the government.

The year 2020 will go down in history for various reasons. COVID-19 has shaken societies, how we work, and every other aspect of our lives. It has also brought in long-lasting economic changes for the world. In March 2020, the Canadian government announced the introduction of the CERB program.

The radical program involved the payment of $500 per week for up to 16 weeks to citizens who lost income due to the pandemic. It is a part of the measures taken by the government to stimulate the economy and cater to its most affected people during these unprecedented times.

The monthly $2,000 was made available without delay by the Canada Revenue Agency (CRA) by hastening the CERB application process. However, there are many cases where CERB applicants are collecting the benefits without qualifying for the funds.

I will discuss the three ways the CRA can take back your $2,000 CERB money.

CERB qualification

The CERB was introduced to help the millions who have lost jobs as a result of government-mandated lockdowns. The CRA outlined criteria that applicants need to fulfill so they can qualify to receive the benefits. If you do not meet the criteria, the CRA will likely take back your CERB, and you might face further action for committing CERB fraud.

Three of the most important factors include:

  • You must not have earned more than $1,000 in the last 14 days.
  • You must have earned at least $5,000 in the last 12 months.
  • You must not have been rehired under the Canada Emergency Wage Subsidy (CEWS) program.

If you have been receiving CERB, you didn’t meet the requirements and didn’t know about them, it would be best to return the CERB money. Over 190,000 people have already returned at least part of the CERB money they collected from the CRA.

There are other ways to generate passive income.

Permanent passive income stream

When it comes to qualification criteria, the CERB has issues. You also need to remember that the benefit is not tax-free. The money you receive will count as part of your taxable income for the next tax season. The CERB is also available for a limited time. With the recent extension, CERB will last 24 weeks with a total possible payout of $12,000.

You can create a tax-free passive income stream that does not expire. You can use your Tax-Free Savings Account (TFSA) to create a portfolio of dividend stocks that can give you substantial passive revenue. You need to buy shares of high-quality companies that offer reliable dividends.

A stock you can consider beginning to build such a portfolio is Fortis Inc. (TSX:FTS)(NYSE:FTS). Fortis is an ideal stock for any portfolio due to its sheer resilience in all market conditions. The utility company enjoys a predictable and stable income.

Fortis does not just regularly pay its shareholders their dividends. It increases the payouts each year. The company is a Canadian Dividend Aristocrat with a 46-year streak of dividend growth. Even in harsh economic conditions like these, the company can generate enough revenue to finance its increasing dividends due to the essential nature of the business.

Foolish takeaway

Assets you store in your TFSA can grow without incurring any taxes. If you have enough shares of high-quality stocks in your TFSA portfolio, you can enjoy the substantial monthly income. This revenue stream does not expire like the CERB, and it does not have eligibility issues. The best part is that you do not have to pay taxes on the dividend income in your TFSA.

Fortis is an ideal stock to begin building such a portfolio due to its reliability and track record for dividend growth.

Speaking of high-quality stocks …

Looking for the Next Potential Netflix? We’ve Got You Covered with These 3 Free Stock Picks

Motley Fool Canada’s market-beating team has just released a new FREE report that gives our three recommendations for the Next Gen Revolution.
Click on the link below for our stock recommendations that we believe could battle Netflix for entertainment dominance.

Click Here to Get Your Free Report Today!

More reading

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends FORTIS INC.

The post WARNING: 3 Ways the CRA Can Take Back Your $2,000 CERB! appeared first on The Motley Fool Canada.



Source link

قالب وردپرس

Continue Reading

Share Market

Manic Monday – S&P 3,000 Holds as We Pass 10M Infections, 500,000 Deaths

Published

on


I guess people ignore stuff all the time.

There were 165,534 NEW cases of Covid-19 YESTERDAY – that's double China's TOTAL number of cases yet President Trump still calls it the China virus while China calls it the President's total failure to contain the virus like they did more than 2 months ago.

ALL Donald Trump had to do was do what the Chinese did and what most of Asia did to contain the virus and this never would have happened.  Instead the President ignored the experts, denied the virus was a thread, did not react fast enough or appropriately when he finally did act and TO THIS DAY, he still isn't doing what needs to be done to contain this Global threat and 38,845 people were infected in the US alone yesterday -  HALF of China's TOTAL infections from the "Kung Flu" as the President likes to call it.

Florida, where I live, had a 6.4% rise in infections on SUNDAY – that's pretty much a doubling rate of 10 days!  We are back to a state of emergency a month after opening but everyone knows it's too late – there's really no going back now.  On Thursday, Trump’s administration asked the Supreme Court to throw out the Affordable Care Act, including its protections for people with pre-existing health conditions, in its entirety — despite the president’s frequent insistence that he will always protect such patients. He has never offered a plan to replace the law known as Obamacare.

On Saturday, Trump said on Twitter that he’d win re-election, once again proclaiming that a “silent majority” supports him. He boasted about high television ratings for his recent campaign events and said “these are the real polls, the Silent Majority, not FAKE POLLS!”  Trump has repeatedly said, falsely, that the U.S. has more cases of Covid-19 because it’s conducting more testing for the disease. He’s also expressed skepticism that some of the reported cases are real.  “You’re going to have a kid with the sniffles, and they’ll say it’s coronavirus,” he said Thursday.

DURING a White House coronavirus task force briefing Friday — its first in two months, held at Health and Human Services headquarters and without Trump — the president tweeted a wanted poster for 15 people who allegedly
continue reading



Source link

قالب وردپرس

Continue Reading

Share Market

The IPOX® Week, July 6, 2020

Published

on


  • Key IPOX Indexes surge. IPOX 100 Europe, (ETF: FPXE) and IPOX International (ETF: FPXI) close week at all-time high.
  • IPOX 100 U.S. (ETF: FPX) adds +3.79% to +6.33% YTD. IPOX International (ETF: FPXI) surges +4.21% to +31.10% YTD. IPOX 100 Europe (ETF: FPXE) gains +3.81% to +10.92% YTD.
  • Hong Kong set for flurry of deals this week.

Key IPOX Indexes surge. IPOX 100 Europe, (ETF: FPXE) and IPOX International (ETF: FPXI) close week at all-time high. The key IPOX Indexes surged last week as: 1) U.S. technology stocks staged another strong technical reversal with the Nasdaq 100 (NDX) closing the week at an all-time high amid 2) Stable U.S. yields despite strong U.S. unemployment numbers with U.S. equity risk declining sharply (VIX: -20.30%). In the U.S., e.g., the diversified, broad-based, FANG-free IPOX 100 U.S. – underlying for the $1.4 billion “FPX” ETF – added +3.79% to +6.33% YTD, lagging the S&P 500 (SPX) by -23 bps. on the week. Here, 81/100 portfolio holdings rose, with the average (median) equally-weighted stock adding +3.20% (+3.35%). Gains extended to the IPOX Indexes focusing on non-U.S. domiciled stocks trading in the U.S. and/or abroad: On the international level, e.g,. the IPOX International (ETF: FPXI)- underlying for the fast-growing $141 million “FPXI” ETF – added another +4.21% to +31.10% YTD, a fresh all-time high, and now a massive +4270 bps. YTD ahead of the MSCI International (ex. U.S.) (MXWOU), the funds benchmark. A big week for the IPOX China Core (CNI) and IPOX Europe (ETF: FPXE) drove the strong

Rotation matters: IPOX International (ETF: FPXI) since 2015

showing in the “FPXI” ETF with continuing gains in the “New Generation” of stocks underweight or ignored in the stale global equity benchmarks, including recent IPO Swiss-based biotech ADC Therapeutics (ADCT US: +18.31%), Sweden’s B2B live casino solutions provider Evolution Gaming (EVO SS: +14.31%), Saudi Arabias health care services provider Riyad-traded 03/20 IPO Dr. Sulaiman Al Habib Medical Services Group (SULAIMAN AB: +13.01%) or H.K. traded “hot pot” restaurant supplier Yihai International (1579 HK: +12.13%). Health care services provider 1 Life Healthcare (ONEM US: +20.09%), CA-based insurance provider Palomar Holdings (PLMR US: +11.34%), drug discovery software maker Schrodinger (SDGR US: +9.66%) and Spin-off refrigeration solutions provider Carrier (CARR US: +9.25%) ranked amongst the best performing portfolio holdings in the IPOX 100 U.S. (ETF: FPX) last week.

Select IPOX® Indexes Price Returns (%) Last Week 2019 2020 YTD
IPOX® Indexes: Global/International
IPOX® Global (IPGL50) (USD) 4.69 27.93 26.44
IPOX® International (IPXI)* (USD) (ETF: FPXI) 4.21 31.37 31.10
IPOX® Indexes: United States
IPOX® 100 U.S. (IPXO)* (USD) (ETF: FPX) 3.79 29.60 6.33
IPOX® ESG (IPXT) (USD) 4.83
IPOX® Indexes: Europe/Nordic
IPOX® 30 Europe (IXTE) (EUR) 4.33 34.55 22.00
IPOX® Nordic (IPND) 4.99 38.52 28.80
IPOX® 100 Europe (IPOE)* (USD) 3.81 30.97 10.92
IPOX® Indexes: Asia-Pacific/China
IPOX® Asia-Pacific (IPTA) (USD) 0.23 4.41 14.49
IPOX® China (CNI) (USD) 5.01 26.31 35.33
IPOX® Japan (IPJP)** (JPY) -1.14 37.91 -2.25

* Basis for ETFs: FPX US, FPX LN, FPXE US, FPXU FP, FPXI US, TCIP110 IT and CME-traded e-mini IPOX® 100 U.S. Futures (IPOM0). Source: Bloomberg L.P. & Refinitiv/Thomson Reuters. For IPOX Alternative Strategies Returns, please contact info@ipox.com

IPOX-linked ETFs (FPX, FPXI, FPXE) Movers (Last Week in %):
TESLA (FPX) 25.94 JOHN LAING (FPXE) -15.37
ZUR ROSE GROUP (FPXE) 20.42 ZOOMINFO TECH (FPX) -12.64
1 LIFE HEALTHCARE (FPX) 20.09 CLOUDERA (FPX) -10.37
ADC THERAPEUTICS (FPX) 18.31 ASTON MARTIN (FPXE) -7.27
EVOLUTION GAMING (FPXE) 14.13 SLACK (FPX) -6.82
SHOPIFY (FPXI) 13.18 WUXI BIOLOGICS (FPXI) -5.75
DR SULAIMAN (FPXI) 13.01 MYOKARDIA (FPX) -4.43
YIHAI INTERN’L (FPXI) 12.13 KOOLEARN TECH. (FPXI) -4.25
SHOP APOTHEKE (FPXE) 11.92 FJORDKRAFT (FPXE) -4.04
SEA (FPXI) 11.81 MEDACTA GROUP (FPXE) -3.73

IPO Deal-flow Review and Outlook: Dun & Bradstreet, Lemonade, and Accolade kick-off July with strong debuts. After holiday, U.S. IPO market set to slow, while Hong Kong sees flurry of deals. At least 9 sizable IPOs commenced trading across the global regions last week, with the average (median) equally weighted deal adding +80.70% (+55.68%) based on the difference between the final offering price and their respective market’s close. Data and analytics veteran Dun & Bradstreet (DNB US: +23.18%) returned to the public with a solid debut just 16 months after taken private by private equity. Unicorns Softbank-backed insurtech Lemonade (LMND US: +139.34%) and health benefits platform Accolade (ACCD US: +35.00%) also soared, while Korean biotech SK Biopharmaceuticals (326030 KS: +236.73%) and massively oversubscribed Chinese medical device maker Kangji (9997 HK: +112.54%) more than doubled abroad. Amid the 4th of July week-end, no deals are scheduled for the U.S. market , while H.K. enters the busiest week since the pandemic with 9 IPOs scheduled with e-cigarette vaping device maker Smoore (6969 HK) lined up. Other IPO news include: 1) Apple device software management company Jamf and fintech unicorn nCino filed for U.S. IPO 2) Brazilian online education platform Uniasselvi revives U.S. IPO plan 3) China Bohai Bank to raise $1.85B in HK’s biggest offer YTD followed by beverage giant Wahaha‘s $1B IPO plan; 4) Online used-car seller Shift to go public in reverse merger.

The post The IPOX® Week, July 6, 2020 appeared first on Low Cost Stock & Options Trading | Advanced Online Stock Trading | Lightspeed |.



Source link

قالب وردپرس

Continue Reading

Trending